Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
WELL Health Technologies Corp (TSE:WELL)
TSX:WELL
Holding TSE:WELL?
Track your performance easily
Earnings Data
Report Date
May 05, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 29, 2019
|% Change Since: 44.69%
|Next Earnings Date:May 29, 2019
Earnings Call Sentiment|Positive
The earnings call was positive overall, with record-setting performances in revenue, EBITDA, and patient visits. Despite challenges like unrealized losses on investments and weather-related impacts, WELL Health's strategic initiatives and strong M&A pipeline position the company for continued growth.Company Guidance
In the Q3 2024 earnings call, WELL Health Technologies Corp. provided guidance that highlights several key performance metrics. The company reported record quarterly revenue of $251.7 million, a 23% year-over-year increase driven by 23% organic growth. Adjusted EBITDA reached $32.7 million, reflecting a 16% growth, while adjusted free cash flow to shareholders rose by 69% compared to Q3 2023. WELL surpassed a $1 billion annualized revenue run rate, achieving this milestone one quarter ahead of schedule. The company also increased its annual revenue guidance to between $985 million and $995 million, attributing the rise to recent clinic acquisitions and robust organic growth. Despite revenue growth, annual adjusted EBITDA guidance remains in the upper half of $125 million to $130 million. Additionally, WELL's leverage ratio improved to approximately 2.5, and the company expects its adjusted free cash flow available to shareholders to be around $55 million for 2024. The strategy includes continued strong execution across all business units, with a focus on enhanced profitability, capital efficiency, and organic growth.Record Quarterly Performance
The third quarter of 2024 was one of the best in WELL Health's history, with record performances in revenue, adjusted EBITDA, free cash flow, patient visits, and organic growth.
Surpassed $1 Billion Revenue Run Rate
WELL Health surpassed $1 billion in annualized revenue run rate, one quarter ahead of schedule, representing a 30-fold increase over five years.
Strong Revenue and EBITDA Growth
Robust revenue growth of 35% in Canadian patient services and 23% overall organic growth, with adjusted EBITDA of $32.7 million reflecting 16% year-over-year growth.
Record Free Cash Flow
Adjusted free cash flow to shareholders increased by 69% year-over-year and 85% quarter-over-quarter, reaching $0.065 per share.
Significant Debt Reduction
Paid down significant debt, improving leverage ratio to approximately 2.5 from 2.67 in the previous quarter.
Record Patient Visits
Achieved a record 1.5 million patient visits in Q3 2024, a 41% year-over-year increase, with 31% organic growth.
Increased Revenue Guidance
Raised 2024 annual revenue guidance to between $985 million and $995 million.
Strong M&A Pipeline
17 LOIs and deals pending closure, representing over $100 million in annual revenue.
Circle Medical and Wisp Growth
Circle Medical's revenue increased by 61% year-over-year with adjusted EBITDA of $2.6 million, and Wisp achieved record revenue and adjusted EBITDA growth.
---
WELL Health Technologies Corp (TSE:WELL) Earnings, Revenues Date & History
TSE:WELL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:WELL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | C$4.52 | C$4.93 | +9.07% |
| Aug 14, 2024 | C$4.64 | C$4.44 | -4.31% |
| May 08, 2024 | C$3.58 | C$3.96 | +10.61% |
| Mar 21, 2024 | C$4.24 | C$3.81 | -10.14% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does WELL Health Technologies Corp (TSE:WELL) report earnings?
WELL Health Technologies Corp (TSE:WELL) is schdueled to report earning on May 05, 2025, TBA Not Confirmed.
What is WELL Health Technologies Corp (TSE:WELL) earnings time?
WELL Health Technologies Corp (TSE:WELL) earnings time is at May 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:WELL EPS forecast?
Currently, no data Available
---